The UK Competition Authority finds that pharmaceutical companies took part in a market sharing arrangements (Lexon / Medreich)

In recent years, the UK CMA has focussed many of its investigations on the pharmaceutical sector. This is partly due to the fact that in the UK, the National Health Service is a public funded body which bears most of the cost of the majority of

Access to this article is restricted to subscribers

Already Subscribed? Sign-in

Access to this article is restricted to subscribers.

Read one article for free

Sign-up to read this article for free and discover our services.

 

PDF Version

Authors

  • Bird & Bird (London)
  • Bird & Bird (London)

Quotation

Ariane Le Strat, Peter Willis, The UK Competition Authority finds that pharmaceutical companies took part in a market sharing arrangements (Lexon / Medreich), 18 June 2019, e-Competitions June 2019, Art. N° 94401

Visites 19

All issues

  • Latest News issue 
  • All News issues
  • Latest Special issue 
  • All Special issues